Company & Sponsor Intelligence
Kafrelsheikh University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting3
Completed2
Countries1
Therapeutic footprint
cerebral_palsymigraine_headachestroke
Indexed studies
NCT06591338Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA
stroke · EgyptPHASE3
stroke · EgyptPHASE3
NCT06058884Predictors of AIS Unfavorable Outcomes
stroke · EgyptPHASE4
stroke · EgyptPHASE4
NCT06591390Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIA
stroke · EgyptPHASE3
stroke · EgyptPHASE3
NCT06243692Lacosamide Versus Topiramate in Migraine
migraine_headache · EgyptPHASE3
migraine_headache · EgyptPHASE3
NCT06653946the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients
stroke · EgyptPHASE4
stroke · EgyptPHASE4
NCT06813599The Best Intervention to Improve Gait Pattern in Children with Spastic Diplegic Cerebral Palsy
cerebral_palsy · EgyptNA
cerebral_palsy · EgyptNA
NCT06120725Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
stroke · EgyptPHASE3
stroke · EgyptPHASE3
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →